Physician

Lindsay Lapresto Thelin, M.D.

According to 2025 Medicare claims, Lindsay Thelin, M.D. (NPI: 1316386980) practices dermatology in the Wenatchee-East Wenatchee, WA market, with the plurality of this provider's patient population coming from Douglas, WA. This provider's primary affiliated billing organization is CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (NPI: 1881642239; TIN: 910171250) and primary practice location at 98801-2028. Thelin is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Thelin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 930 traditional Medicare patients, billed 4,516 HCPCS/CPT codes, and received $114,986 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,109 prescription claims across 398 beneficiaries totaling $515,073 in drug costs, led by Dupixent Pen (Dupilumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $41,447 to $114,986. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,405 to $515,073. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$115K2017 Medicare payment: $41,447 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $62,402 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $93,208 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $86,576 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $92,784 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $100,618 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $109,468 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $114,986 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20173921,481$41,447
20185782,692$62,402
20198073,875$93,208
20208203,750$86,576
20217713,526$92,784
20227033,392$100,618
20239014,039$109,468
20249304,516$114,986

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$258K$515K2015 Drug cost: $6,405 (USD; Tot_Drug_Cst)2016 Drug cost: $4,291 (USD; Tot_Drug_Cst)2017 Drug cost: $43,486 (USD; Tot_Drug_Cst)2018 Drug cost: $56,131 (USD; Tot_Drug_Cst)2019 Drug cost: $130,596 (USD; Tot_Drug_Cst)2020 Drug cost: $271,174 (USD; Tot_Drug_Cst)2021 Drug cost: $184,101 (USD; Tot_Drug_Cst)2022 Drug cost: $104,351 (USD; Tot_Drug_Cst)2023 Drug cost: $137,281 (USD; Tot_Drug_Cst)2024 Drug cost: $515,073 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R13$6,405
2016N/R40$4,291
2017132232$43,486
2018234458$56,131
2019296677$130,596
2020298735$271,174
2021279793$184,101
2022247621$104,351
2023351958$137,281
20243981,109$515,073

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more177215$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more686826$43
17000Destruction of precancer skin growth, 1 growth448565$34
11102Biopsy of related skin growth, first growth188203$19
17003Destruction of precancer skin growth, 2-14 growths3521,895$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab37994$141,228
Humira(Cf) PenAdalimumab13364$88,194
Dupixent SyringeDupilumab16448$59,912
Clobetasol PropionateClobetasol Propionate1253,837$4,642
FluorouracilFluorouracil601,581$3,481

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Lindsay Lapresto Thelin, M.D.?

Tedicare shows public-source Medicare data for Lindsay Lapresto Thelin, M.D. (NPI 1316386980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lindsay Lapresto Thelin, M.D. have ACO affiliation data?

Lindsay Lapresto Thelin, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Lindsay Lapresto Thelin, M.D.?

Lindsay Lapresto Thelin, M.D. is linked to CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (billing NPI 1881642239) in the available physician profile data.

Does Lindsay Lapresto Thelin, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.